Used in biomedical research to quantify levels of VEGFR-2 in cell culture supernatants, serum, plasma, and tissue extracts. Helps in studying angiogenesis, the process of new blood vessel formation, which is critical in cancer development, wound healing, and inflammatory diseases. Enables researchers to evaluate the effectiveness of anti-angiogenic drugs and monitor disease progression in conditions like diabetic retinopathy, age-related macular degeneration, and various cancers. Supports high-throughput screening and biomarker validation in preclinical studies.